NCT00941655 Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial Status COMPLETED Phase PHASE3
NCT00940303 OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00938470 Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Status COMPLETED Phase PHASE2
NCT00932438 Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab Status COMPLETED Phase PHASE1/PHASE2
NCT00920868 XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib Status COMPLETED Phase PHASE1
NCT00909987 Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum Status COMPLETED Phase PHASE2
NCT00884767 Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin Status UNKNOWN Phase PHASE2
NCT00873275 Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00865189 A Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE2
NCT00861094 Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT00851084 Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00849615 Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction Status COMPLETED Phase PHASE2
NCT00831181 Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer Status COMPLETED Phase PHASE2
NCT00828672 Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE2
NCT00816543 Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma Status COMPLETED Phase PHASE2
NCT00803647 A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver Status COMPLETED Phase PHASE2